Sable Systems

Sable Systems - By scientists, for scientists

Sable Systems is the world’s most trusted provider of tools and expertise for research in the metabolic sciences. The company provides integrated platforms for metabolic and behavioral phenotyping and testing (e.g. BAT activation, gut microbiota, ingestive behavior) of animal models of diabetes and other obesity-related diseases, enhancing a true translational approach from animal models to man. Only Sable Systems spans the entire model range, from microbiome to Drosophila, rodent to human.

Sable Systems is eliminating the disconnect between scientists and the people who develop their instruments. We merge authoritative expertise in metabolic physiology  and biophysics with an inventive spark to create precision tools for metabolic measurement, neurophysiology and environmental science.

The Promethion Core™ metabolic and behavioral measurement system for rodent research delivers highest resolution data regardless of study size. This enables greater statistical power with fewer animals and simultaneous testing of more hypotheses. The integrated data platform features continuous live evaluation of system performance, animal welfare and data quality at a glance.

Systems can be expanded by cutting-edge features like analysis of stable isotopes or high-precision methane monitoring at any time.


Prome­thion CORE Meta­bolic & Be­hav­ior Phe­no­typ­ing Plat­form

Sta­ble Iso­tope An­a­lyzer

Sable Sys­tems - From Fly to Mouse to Hu­man

Sable Sys­tems Prod­uct Overview

German Center for Diabetes Research

The German Center for Diabetes Research (DZD) is one of six German centers of health research. It brings together experts in the field of diabetes research and combines basic research, epidemiology and clinical applications. Using a novel, integrative research approach, the DZD seeks to make a major contribution to developing a successful, personalized prevention, diagnosis and treatment of diabetes mellitus. The members of the network are Helmholtz Munich, the German Diabetes Center (DDZ) in Düsseldorf, the German Institute of Human Nutrition (DIfE) in Potsdam-Rehbrücke, the Institute for Diabetes Research and Metabolic Diseases of Helmholtz Zentrum München at the University of Tübingen and the Paul Langerhans Institute Dresden of Helmholtz Zentrum München at the TU Dresden Medical Center, associated partners at the universities in Heidelberg, Cologne, Leipzig, Lübeck and Munich as well as additional project partners.  www.dzd-ev.de


We thank the DZD for being a cooperation partner of the Helmholtz Diabetes Conference and for sponsoring the Helmholtz Diabetes Lecture, this year awarded to Prof. Rudolf Zechner of the University of Graz.


Eli Lilly and Company

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better." 

More than 145 years later, Eli Lilly remains committed to his vision through every aspect of their business and the people they serve starting with those who take their medicines, and extending to health care professionals, employees and the communities in which we live. 


We thank Eli Lilly and Company for supporting the Helmholtz Young Investigator in Diabetes (HeIDi) Awards.